-
1
-
-
23944516534
-
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease
-
Brodaty, H., Corey-Bloom, J., Potocnik, F. C., Truyen, L., Gold, M. and Damaraju, C. R. (2005). Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 20, 120-132.
-
(2005)
Dementia and Geriatric Cognitive Disorders
, vol.20
, pp. 120-132
-
-
Brodaty, H.1
Corey-Bloom, J.2
Potocnik, F.C.3
Truyen, L.4
Gold Damaraju M, C.R.5
-
2
-
-
33746825134
-
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
-
Cummings, J. L., Schneider, E., Tariot, P. N. and Graham, S. M. (2006). Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology, 67, 57-63.
-
(2006)
Neurology
, vol.67
, pp. 57-63
-
-
Cummings, J.L.1
Schneider, E.2
Tariot, P.N.3
Graham, S.M.4
-
3
-
-
0036424378
-
Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease
-
Gauthier, S., Feldman, H., Hecker, J., Vellas, B., Emir, B. and Subbiah, P. (2002). Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease. Current Medical Research and Opinion, 18, 347-354.
-
(2002)
Current Medical Research and Opinion
, vol.18
, pp. 347-354
-
-
Gauthier, S.1
Feldman, H.2
Hecker, J.3
Vellas, B.4
Emir, B.5
Subbiah, P.6
-
4
-
-
0024300219
-
Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirksamkeit von Ginkgo-biloba-Extrakt
-
Halama, P., Bartsch, G. andMeng, G. (1988). Hirnleistungsstörungen vaskulärer Genese. Randomisierte Doppelblindstudie zur Wirksamkeit von Ginkgo-biloba-Extrakt. Fortschritte der Medizin, 106: 408-412.
-
(1988)
Fortschritte der Medizin
, vol.106
, pp. 408-412
-
-
Halama, P.1
Bartsch, G.2
Meng, G.3
-
5
-
-
0024408951
-
Einfluß von Ginkgo biloba-Extrakt auf neurophysiologische und psychometrische Meßergebnisse bei Patienten mit hirnorganischem Psychosyndrom. Eine Doppelblindstudie gegen Placebo
-
Hofferberth, B. (1989). Einfluß von Ginkgo biloba-Extrakt auf neurophysiologische und psychometrische Meßergebnisse bei Patienten mit hirnorganischem Psychosyndrom. Eine Doppelblindstudie gegen Placebo. Arzneimittelforschung, 39, 918-922.
-
(1989)
Arzneimittelforschung
, vol.39
, pp. 918-922
-
-
Hofferberth, B.1
-
6
-
-
80055006038
-
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomized controlled trial
-
Ihl, R. et al. (2011a). Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomized controlled trial. International Journal of Geriatric Psychiatry, 26, 1186-1194.
-
(2011)
International Journal of Geriatric Psychiatry
, vol.26
, pp. 1186-1194
-
-
Ihl, R.1
-
7
-
-
79551613305
-
World Federation of Societies of Biological Psychiatry guidelines for the biological treatment of Alzheimer's disease
-
And the WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias.
-
Ihl, R., Frölich, L., Winblad, B., Schneider, L., Burns, A., Möller, H. J. and the WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias. (2011b). World Federation of Societies of Biological Psychiatry guidelines for the biological treatment of Alzheimer's disease. World Journal of Biological Psychiatry, 12, 2-32.
-
(2011)
World Journal of Biological Psychiatry
, vol.12
, pp. 2-32
-
-
Ihl, R.1
Frölich, L.2
Winblad, B.3
Schneider, L.4
Burns, A.5
Möller, H.J.6
-
8
-
-
0029871249
-
Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
-
Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W. and Hörr, R. (1996). Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry, 29, 47-56.
-
(1996)
Pharmacopsychiatry
, vol.29
, pp. 47-56
-
-
Kanowski, S.1
Herrmann, W.M.2
Stephan, K.3
Wierich, W.4
Hörr, R.5
-
9
-
-
0346373723
-
Ginkgo biloba extract EGb 761® in dementia: Intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial
-
Kanowski, S. and Hoerr, R. (2003). Ginkgo biloba extract EGb 761® in dementia: Intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry, 36, 297-303.
-
(2003)
Pharmacopsychiatry
, vol.36
, pp. 297-303
-
-
Kanowski, S.1
Hoerr, R.2
-
10
-
-
0030759072
-
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia
-
Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M. and Schatzberg, A. F. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. Journal of the American Medical Association, 278, 1327-1333.
-
(1997)
Journal of the American Medical Association
, vol.278
, pp. 1327-1333
-
-
Le Bars, P.L.1
Katz, M.M.2
Berman, N.3
Itil, T.M.4
Freedman, A.M.5
Schatzberg, A.F.6
-
11
-
-
0034125340
-
A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761® in dementia
-
Le Bars, P. L., Kieser, M. and Itil, K. Z. (2000). A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761® in dementia. Dementia and Geriatric Cognitive Disorders, 11, 230-237.
-
(2000)
Dementia and Geriatric Cognitive Disorders
, vol.11
, pp. 230-237
-
-
Le Bars, P.L.1
Kieser, M.2
Itil, K.Z.3
-
12
-
-
33846820304
-
Ginkgo biloba special extract in dementia with neuropsychiatric features: A randomized, placebo-controlled, double-blind clinical trial
-
Napryeyenko, O. and Borzenko, I. for the GINDEM-NP Study Group. (2007). Ginkgo biloba special extract in dementia with neuropsychiatric features: a randomized, placebo-controlled, double-blind clinical trial. Arzneimittelforschung, 57, 4-11.
-
(2007)
Arzneimittelforschung
, vol.57
, pp. 4-11
-
-
Napryeyenko, O.1
Borzenko, I.2
-
13
-
-
28244446721
-
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type
-
Schneider, L. S., DeKosky, S. T., Farlow, M. R., Tariot, P. N., Hoerr, R. and Kieser, M. (2005). A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Current Alzheimer Research, 2, 541-551.
-
(2005)
Current Alzheimer Research
, vol.2
, pp. 541-551
-
-
Schneider, L.S.1
Dekosky, S.T.2
Farlow, M.R.3
Tariot, P.N.4
Hoerr, R.5
Kieser, M.6
-
14
-
-
34548387614
-
Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: Findings from a randomised controlled trial
-
Scripnikov, A., Khomenko, A., Napryeyenko, O. and the GINDEM-NP Study Group. (2007). Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. Wien Med Wochenschr, 157, 295-300.
-
(2007)
Wien Med Wochenschr
, vol.157
, pp. 295-300
-
-
Scripnikov, A.1
Khomenko, A.2
Napryeyenko, O.3
-
15
-
-
0028262405
-
A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration
-
Stern, R. G., Mohs, R. C, Davidson, M., Schmeidler, J., Silverman, J., Kramer-Ginsberg, E., Searcey, T., Bierer, L. and Davis, K. L. (1994). A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. American Journal of Psychiatry, 151, 390-396.
-
(1994)
American Journal of Psychiatry
, vol.151
, pp. 390-396
-
-
Stern, R.G.1
Mohs, R.C.2
Davidson, M.3
Schmeidler, J.4
Silverman, J.5
Kramer-Ginsberg, E.6
Searcey, T.7
Bierer, L.8
Davis, K.L.9
-
16
-
-
0022549705
-
Traitement des troubles du vieillissement cérébral par l'extrait de Ginkgo biloba. Etude longitudinale multicentrique à double insu face au placebo
-
Taillandier, J., Ammar, A., Rabourdin, J. P., Ribeyre, J. P., Pichon, J., Niddam, S. and Pierart, H. (1986). Traitement des troubles du vieillissement cérébral par l'extrait de Ginkgo biloba. Etude longitudinale multicentrique à double insu face au placebo. La Presse Médicale, 15, 1583-1587.
-
(1986)
La Presse Médicale
, vol.15
, pp. 1583-1587
-
-
Taillandier, J.1
Ammar, A.2
Rabourdin, J.P.3
Ribeyre, J.P.4
Pichon, J.5
Niddam, S.6
Pierart, H.7
-
17
-
-
0034720864
-
A 5-month, randomized, placebo-controlled trial of galantamine in AD
-
Tariot, P. N., Solomon, P. R., Morris, J. C, Kershaw, P., Lilienfeld, S. and Ding, C (2000). A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology, 54, 2269-2276.
-
(2000)
Neurology
, vol.54
, pp. 2269-2276
-
-
Tariot, P.N.1
Solomon, P.R.2
Morris, J.C.3
Kershaw, P.4
Lilienfeld, S.5
Ding, C.6
-
18
-
-
0037371058
-
Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: Results of a 24-week, double-blind, placebo-controlled study
-
Tune, L., Tiseo, P. J., Ieni, J., Perdomo, C, Pratt, R. D., Votaw, J. R., Jewart, R. D. and Hoffman, J. M. (2003). Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study. American Journal of Geriatric Psychiatry, 11, 169-177.
-
(2003)
American Journal of Geriatric Psychiatry
, vol.11
, pp. 169-177
-
-
Tune, L.1
Tiseo, P.J.2
Ieni, J.3
Perdomo, C.4
Pratt, R.D.5
Votaw, J.R.6
Jewart, R.D.7
Hoffman, J.M.8
-
19
-
-
34249873186
-
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease
-
van Dyck, C. H., Tariot, P. N., Meyers, B. and Malca Resnick, E. (2007). A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. Alzheimer Disease and Associated Disorders, 21, 136-143.
-
(2007)
Alzheimer Disease and Associated Disorders
, vol.21
, pp. 136-143
-
-
Van Dyck, C.H.1
Tariot, P.N.2
Meyers, B.3
Malca Resnick, E.4
-
20
-
-
0022560252
-
Primary degenerative dementia: Therapy with Ginkgo biloba extract. Placebo-controlled double-blind and comparative study
-
in German
-
Weitbrecht, W. U. and Jansen, W. (1986). [Primary degenerative dementia: therapy with Ginkgo biloba extract. Placebo-controlled double-blind and comparative study]. Fortschritte der Medizin, 104, 199-202 (in German).
-
(1986)
Fortschritte der Medizin
, vol.104
, pp. 199-202
-
-
Weitbrecht, W.U.1
Jansen, W.2
-
21
-
-
84987486738
-
A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly
-
Wesnes, K., Simmons, D., Rook, M. and Simpson, P. (1987). A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. Human Psychopharmacology, 2, 159-169.
-
(1987)
Human Psychopharmacology
, vol.2
, pp. 159-169
-
-
Wesnes, K.1
Simmons, D.2
Rook, M.3
Simpson, P.4
-
22
-
-
67949102170
-
Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial
-
Yancheva, S., Ihl, R., Nikolova, G., Panayotov, P., Schlaefke, S. and Hoerr, R. for the GINDON Study Group (2009). Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging & Mental Health, 13, 183-190.
-
(2009)
Aging & Mental Health
, vol.13
, pp. 183-190
-
-
Yancheva, S.1
Ihl, R.2
Nikolova, G.3
Panayotov, P.4
Schlaefke, S.5
Hoerr, R.6
|